MERSANA THERAPEUTICS INC

CUSIP: 59045L106 Class: COM

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 15,600 Value ($000) $22 Avg Close Range
Q2 2024
Shares 176,029 Value ($000) $354 Avg Close Range
Q1 2024
Shares 38,433 Value ($000) $172 Avg Close Range
Q4 2023
Shares 157,800 Value ($000) $366 Avg Close Range
Q3 2023
Shares 157,800 Value ($000) $200 Avg Close Range
Q2 2023
Shares 2,711,310 Value ($000) $8,920 Avg Close Range
Q1 2023
Shares 2,496,710 Value ($000) $10,261 Avg Close Range
Q4 2022
Shares 2,523,984 Value ($000) $14,791 Avg Close Range
Q3 2022
Shares 528,468 Value ($000) $3,572 Avg Close Range
Q1 2022
Shares 32,667 Value ($000) $130 Avg Close Range
Q3 2021
Shares 384,736 Value ($000) $3,628 Avg Close Range
Q2 2021
Shares 19,845 Value ($000) $269 Avg Close Range
Q1 2021
Shares 152,110 Value ($000) $2,461 Avg Close Range
Q4 2020
Shares 99,098 Value ($000) $2,636 Avg Close Range
Q3 2019
Shares 121,543 Value ($000) $192 Avg Close Range
Q2 2019
Shares 172,381 Value ($000) $698 Avg Close Range
Q1 2019
Shares 26,741 Value ($000) $141 Avg Close Range